STK-002, an Antisense Oligonucleotide (ASO) for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), is Taken Up by Retinal Ganglion Cells (RGC) and Upregulates OPA-1 Protein Expression After Intravitreal Administration to Non-human Primates (NHPs)

被引:0
|
作者
Anderson, Karen [1 ]
Venkatesh, Aditya [1 ]
McKenty, Taylor [1 ]
Slate, Deidre [1 ]
Lin, Qian [1 ]
Ravipaty, Shobha [1 ]
Jacobson, Sarah [1 ]
Christiansen, Anne [1 ]
Benmohamed, Radhia [1 ]
Hoger, Jeff [1 ]
Liau, Gene [1 ]
机构
[1] Stoke Therapeut Inc, Bedford, MA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1111
引用
收藏
页数:3
相关论文
共 2 条
  • [1] STK-002, an Antisense Oligonucleotide (ASO) for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), Localizes to Retinal Ganglion Cells (RGC) and Upregulates OPA-1 Protein Expression After Intravitreal Administration to Non-Human Primates (NHP)
    Venkatesh, Aditya
    McKenty, Taylor
    Slate, Deidre
    Lin, Qian
    Ravipaty, Shobha
    Jacobson, Sarah
    Christiansen, Anne
    Anderson, Karen
    Benmohamed, Radhia
    Hoger, Jeff
    Liau, Gene
    MOLECULAR THERAPY, 2022, 30 (04) : 9 - 9
  • [2] Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells
    Venkatesh, Aditya
    McKenty, Taylor
    Ali, Syed
    Sonntag, Donna
    Ravipaty, Shobha
    Cui, Yanyan
    Slate, Deirdre
    Lin, Qian
    Christiansen, Anne
    Jacobson, Sarah
    Kach, Jacob
    Lim, Kian Huat
    Srinivasan, Vaishnavi
    Zinshteyn, Boris
    Aznarez, Isabel
    Huryn, Laryssa A.
    Li, Zhiyu
    Hufnagel, Robert B.
    Liau, Gene
    Anderson, Karen
    Hoger, Jeff
    NUCLEIC ACID THERAPEUTICS, 2024, 34 (05) : 221 - 233